Adage Capital Partners Gp, L.L.C. Ocular Therapeutix, Inc Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.6 Billion
- Q3 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 3,750,000 shares of OCUL stock, worth $33.1 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
3,750,000
Previous 3,695,047
1.49%
Holding current value
$33.1 Million
Previous $25.3 Million
29.08%
% of portfolio
0.06%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding OCUL
# of Institutions
172Shares Held
138MCall Options Held
150KPut Options Held
225K-
Summer Road LLC West Palm Beach, FL14.4MShares$127 Million98.8% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$113 Million11.5% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$112 Million4.08% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$102 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.38MShares$74 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $680M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...